Navigation Links
Partnership to accelerate Trudeau Institute discoveries to patient care

Saranac Lake, N.Y. - The Trudeau Institute and Health Research Incorporated (HRI) have established a unique partnership aimed at advancing the commercialization of medical and scientific discoveries made at the institute to maximize their benefit to public health worldwide.

The Trudeau Institute was originally created as a tuberculosis treatment center in 1884. With the advent of antibiotics in the middle of the last century, however, the institute was reorganized as a research organization, with a specific mission to learn how the immune system responds to infectious diseases. Today, Trudeau is credited with a host of scientific discoveries that have contributed greatly to the understanding of the immune system.

Under the exclusive agreement between the two organizations, HRI will provide technology transfer services to Trudeau, including market evaluation, intellectual property evaluation and protection, business development, marketing, licensing, and new venture formation.

The arrangement provides Trudeau with access to HRI professional staff and resources both in technology transfer and sponsored research management. HRI brings a well-developed network of corporate licensing and business contacts, funding sources, investors, and researchers. Each of Trudeau's existing and future inventions will be subject to a methodical approach to analyze, protect and license promising technologies.

The Trudeau Institute has historically managed these activities internally. "Partnering with HRI will reduce the need for day-to-day technology management and, importantly, will add HRI's technology-transfer expertise, said Steve Smiley, director of corporate relations and member of Trudeau's scientific faculty. "This combination will allow our scientists to focus on research, while still managing the strategic decisions in intellectual property and licensing."

Since the passage of the Bayh-Dole Act of 1980, HRI has established hundreds of patents and technology licenses that have resulted in the commercialization of medical advancements, such as the Prostate Specific Antigen test ("PSA test"), HIV-1 co-receptor usage test, photodynamic cancer therapy, assistive communication devices for persons with spinal cord injuries, and several pharmaceuticals.

"As a basic research institution, discoveries made at the Trudeau Institute often lead to vaccines and other therapeutic strategies that improve human health," stated David L. Woodland, president of the institute. "Trudeau's mission is to improve health and protect people from disease. This partnership will help us to more rapidly transition our discoveries from the laboratory bench to the patient's bedside."

"The Trudeau Institute is a gem, a place where world-class scientists are drawn to push the envelope of immunology research aimed at diseases affecting millions of people worldwide," said Michael Nazarko, executive director of HRI. "Forging strategic relationships geared to delivering Trudeau's pioneering biomedical research to patients is consistent with HRI's mission of advancing the interests of public health," he added.


Contact: Brian Turner
Trudeau Institute

Related biology news :

1. New partnership offers outsourced R&D in membrane biology
2. UD hosts conference on knowledge-based partnerships Nov. 2
3. Elsevier announces new journal partnership for 2008
4. Emory, Ohio State launch partnership in predictive and personalized health care
5. United Water, in partnership with Stevens, wins Management Innovation Award
6. MIT, Eni announce energy research partnership
7. GM, Coskata partnership builds on Oklahoma State University biofuels research
8. Oak Ridge to lead auto supplier R&D partnership
9. Citizen Science -- a celebration of partnership between academia and local people
10. Cell Press announces new partnership with the Biophysical Society
11. KAUST announces academic excellence alliance partnership with Imperial College London
Post Your Comments:
Related Image:
Partnership to accelerate Trudeau Institute discoveries to patient care
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... the explosion of technology-enabled health and wellness, and the ... book, The Internet of Healthy Things ... or smartphones even existed, Dr. Kvedar, vice president, Connected ... health care delivery, moving care from the hospital or ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... Nov. 24, 2015  Asia-Pacific (APAC) holds the ... (CRO) market. The trend of outsourcing to low-cost ... but higher volume share for the region in ... however, margins in the CRO industry will improve. ... ( ), finds that the market ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... year and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual ... November 2015, where ISPE hosted the largest number of attendees in more than ...
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
Breaking Biology Technology: